Speakers 2009

    • Presentation

    • (chairman)

    View more
  • ALBERTI Alfredo

    Italy

      Presentation

    • What are the co-morbidities influencing the management of patients and the response to therapy ?

    • Management of non naive patients with hepatitis C (chairman)

    View more
  • ALTER Harvey

    USA

      Presentation

    • 1989 -2009 : HCV twenty years after From B to non B to C : the historical evolution of hepatitises viruses

    View more
  • ANTAKI Nabil

    Syria

      Presentation

    • Genotype 4 : how to treat ?

    View more
  • ASSELAH Tarik

    France

      Presentation

    • New drugs : Enzyme inhibitors

    View more
  • BEDOSSA Pierre

    France

      Presentation

    • Non invasive fibrosis markers and/or liver biopsy ?

    View more
  • BELHADJ BRIK Najet

    Tunisia

      Presentation

    • French Luncheon : comment prendre en charge les patients atteints d’hépatite B avec les médicaments disponibles dans mon pays

    View more
  • BENAZZOUZ Mustapha

    Morocco

      Presentation

    • French Luncheon : comment prendre en charge les patients atteints d’hépatite B avec les médicaments disponibles dans mon pays

    View more
  • BERKANE Saadi

    Algeria

      Presentation

    • French Luncheon : comment prendre en charge les patients atteints d’hépatite C avec les médicaments disponibles dans mon pays.

    View more
  • BONINO Feruccio

    Italy

      Presentation

    • (chairman)

    • Hepatitis B: predictors and endpoints revisited? (chairman)

    View more
    • Presentation

    • (chairman)

    View more
  • BRUIX Jordi

    Spain

      Presentation

    • New drugs for hepatocellular carcinoma

    View more
  • BRUNETTO Maurizia

    Italy

      Presentation

    • New endpoints. Back to the future with Australia Antigen ?

    View more
  • COLOMBO Massimo

    Italy

      Presentation

    • End stage HBV-related liver disease: what’s left to do? (chairman)

    • Screening and diagnosis of hepatocellular carcinoma

    View more
  • CRAXI Antonio

    Italy

      Presentation

    • Optimal therapy in genotype 2 and 3 patients

    View more
  • DHUMEAUX Daniel

    France

      Presentation

    • French Luncheon : comment prendre en charge les patients atteints d’hépatite C avec les médicaments disponibles dans mon pays. (chairman)

    View more
  • DI BISCEGLIE Adrian

    USA

      Presentation

    • Hepatocellular carcinoma (chairman)

    View more
  • DURAND François

    France

      Presentation

    • End stage HBV-related liver disease: what’s left to do?

    View more
  • DUSHEIKO Geoffrey

    UK

      Presentation

    • HBeAg-positive chronic hepatitis B (chairman)

    View more
  • ESSAID EL FEYDI Abdellah

    Maroc

      Presentation

    • French Luncheon : comment prendre en charge les patients atteints d’hépatite C avec les médicaments disponibles dans mon pays.

    View more
  • ESTEBAN Rafael

    Spain

      Presentation

    • Hepatocellular carcinoma (chairman)

    View more
  • FERENCI Peter

    Austria

      Presentation

    • Optimizing therapy in real life illustrated with clinical cases (chairman)

    View more
  • FOSTER Graham

    UK

      Presentation

    • Optimizing therapy in real life illustrated with clinical cases (chairman)

    View more
  • HADZIYANNIS Stephanos

    Greece

      Presentation

    • HBeAg negative chronic hepatitis B (chairman)

    View more
  • HEATHCOTE Jenny

    Canada

      Presentation

    • Retreatment : who and how ?

    View more
  • HORBAN Andrzej

    Poland

      Presentation

    • Clinical Management of hepatitis C in an environment with limited access to treatment

    View more
  • HOUGHTON Michael

    USA

      Presentation

    • The HCV discovery

    View more
  • IVASHKIN Vladimir

    Russia

      Presentation

    • How to manage patients with hepatitis B with limited access to care ?

    View more
  • JIA Jidong

    China

      Presentation

    • How to manage patients with hepatitis B with limited access to care ?

    View more
  • JONAS Maureen

    USA

      Presentation

    • Hepatitis B and pregnancy : an underestimated issue

    View more
  • KAMAL Sanaa

    Egypt

      Presentation

    • Optimal therapy in genotype 4 patients

    • Genotype 4 : how to treat ?

    View more
  • LAMPERTICO Pietro

    Italy

      Presentation

    • Why do I treat my patients with nucleos(t)ide analogs ?

    • How to optimize the management of my HBeAg negative patient?

    View more
  • LAU George

    Hong Kong

      Presentation

    • Why do I treat my patients with pegylated interferon ?

    View more
  • LAVANCHY Daniel

    Switzerland

      Presentation

    • The burden of hepatitis C in Europe. Epidemiology, actions to increase awareness and access to care (chairman)

    • The global burden of hepatitis C

    View more
  • LEE Sam

    Canada

      Presentation

    • Why do I treat my patients with nucleos(t)ide analogs ?

    View more
  • LIAW Yun-Fan

    Taiwan

      Presentation

    • Natural history of HBV and long-term outcome under treatment

    View more
  • MANGIA Alessandra

    Italy

      Presentation

    • Management of non naive patients with hepatitis C

    View more
  • MANNS Michael

    Germany

      Presentation

    • (chairman)

    View more
  • MARCELLIN Patrick

    France

      Presentation

    • Introduction : Viral Hepatitis in 2009

    • State of the Art Lecture

    • EASL clinical pratice guidelines : management of chronic hepatitis B

    • Conclusion and perspectives

    View more
  • MATHURIN Philippe

    France

      Presentation

    • The burden of hepatitis C in Europe. Epidemiology, actions to increase awareness and access to care

    View more
  • MOUCARI Rami

    United Arab Emirates

      Presentation

    • Hepatitis B: predictors and endpoints revisited?

    View more
  • MUEHLBERGER Nikolai

    Austria

      Presentation

    • The burden of hepatitis C in Europe. Epidemiology, actions to increase awareness and access to care

    View more
  • OMATA Masao

    Japan

      Presentation

    • (chairman)

    View more
  • PAWLOTSKY Jean-Michel

    France

      Presentation

    • How to use the virological tools for the optimal follow up of chronic hepatitis C

    View more
  • PERRILLO Robert

    USA

      Presentation

    • Why do I treat my patients with pegylated interferon ?

    • How to manage patients with hepatitis B with limited access to care ? (chairman)

    View more
  • PETERS Marion

    USA

      Presentation

    • Clinical case

    View more
  • POL Stanislas

    France

      Presentation

    • Management of HIV-HCV co-infected patients (chairman)

    • HBeAg-positive chronic hepatitis B (chairman)

    View more
    • Presentation

    • Hepatitis D: the come back ?

    View more
  • ROCKSTROH Juergen

    Germany

      Presentation

    • Management of HIV-HCV co-infected patients

    View more
  • SAMUEL Didier

    France

      Presentation

    • (chairman)

    View more
  • SARRAZIN Christoph

    Germany

      Presentation

    • Management of non naive patients with hepatitis C

    • French Luncheon : comment prendre en charge les patients atteints d’hépatite C avec les médicaments disponibles dans mon pays.

    View more
  • SCHIFF Eugene

    USA

      Presentation

    • Clinical Management of hepatitis C in an environment with limited access to treatment (chairman)

    • Clinical case

    View more
  • SEEFF Leonard

    USA

      Presentation

    • The history of the "natural history" of hepatitis C

    View more
  • SHIFFMAN Mitchell

    USA

      Presentation

    • What future for ribavirin ?

    View more
  • TREPO Christian

    France

      Presentation

    • French Luncheon : comment prendre en charge les patients atteints d’hépatite B avec les médicaments disponibles dans mon pays (chairman)

    View more
  • WRIGHT Teresa

    USA

      Presentation

    • (chairman)

    View more
  • YURDAYDIN Cihan

    Turkey

      Presentation

    • (chairman)

    View more
  • ZARSKI Jean-Pierre

    France

      Presentation

    • HBeAg negative chronic hepatitis B (chairman)

    • How to optimize the management of my HBeAg negative patient? (chairman)

    View more
  • ZEUZEM Stefan

    Germany

      Presentation

    • Optimizing therapy in real life illustrated with clinical cases Optimal therapy in genotype 1 patients

    View more
  • ZOULIM Fabien

    France

      Presentation

    • How to prevent, diagnose and overcome resistance under nucleos(t)ide analogs ?

    View more